Pure Global

Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients. - Trial NCT06061536

Access comprehensive clinical trial information for NCT06061536 through Pure Global AI's free database. This Phase 2 trial is sponsored by Shanxi Kangbao Biological Product Co., Ltd. and is currently Not yet recruiting. The study focuses on HIV. Target enrollment is 64 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06061536
Phase 2
Not yet recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06061536
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients.
A Randomized, Controlled, Open-label, Dose-exploration Study to Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients Who Have Not Received Antiviral Treatment Before.

Study Focus

HIV

Lipovirtide 10mg

Interventional

drug

Sponsor & Location

Shanxi Kangbao Biological Product Co., Ltd.

Timeline & Enrollment

Phase 2

Oct 20, 2023

Oct 30, 2024

64 participants

Primary Outcome

HIV-1 RNA 50 copies/ml

Summary

A randomized, controlled, open-label, dose-exploration study to assess the effectiveness and
 safety of Lipovirtide combined with nucleoside drugs in HIV-infected patients who have not
 received antiviral treatment before.

ICD-10 Classifications

Human immunodeficiency virus [HIV] disease
Human immunodeficiency virus [HIV] disease resulting in other conditions
HIV disease resulting in other viral infections
Unspecified human immunodeficiency virus [HIV] disease
Human immunodeficiency virus [HIV] disease resulting in other specified diseases

Data Source

ClinicalTrials.gov

NCT06061536

Non-Device Trial